NCT02619409 - Evaluation of the Duration of Bupivacaine Spinal Block in Orthopedic Procedures With and Without Epinephrine Wash | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 11, 2016

Primary Completion Date

October 20, 2016

Study Completion Date

October 20, 2016

Conditions

Arthropathy of HipArthropathy of Knee

Interventions

DRUG

Bupivacaine Only

The bupivacaine only group will receive bupivacaine 0.5% 3cc plus sterile saline 0.1cc.

DRUG

EPI25

The EPI25 group will receive bupivacaine 0.5% 3cc, epinephrine 1:1000 0.025cc, and sterile saline 0.075cc.

DRUG

EPI50 group

The EPI50 group will receive bupivacaine 0.5% 3cc, epinephrine 1:1000 0.05cc, and sterile saline 0.05cc

DRUG

EPI75 group

The EPI75 group will receive bupivacaine 0.5% 3cc, epinephrine 1:1000 0.075cc, and sterile saline 0.025%.

DRUG

EPI100 group

The EPI100 group will receive bupivacaine 0.5% 3cc, and epinephrine 1:1000 0.1cc.

Trial Locations (1)

Medical University of South Carolina, Charleston

All Listed Sponsors

lead

Medical University of South Carolina

OTHER